Table V.
Association of CTAG2 expression with the clinicopathological features of hepatocellular carcinoma patients from the First Affiliated Hospital of China Medical University.
| CTAG2 expression, n (%) | |||||
|---|---|---|---|---|---|
| Characteristic | Category | n | Low | High | P-value |
| Sex | Female | 8 | 5 (62.5) | 3 (37.5) | 0.361 |
| Male | 38 | 17 (44.7) | 21 (55.3) | ||
| Age, years | <60 | 34 | 14 (41.2) | 20 (58.8) | 0.129 |
| ≥60 | 12 | 8 (66.7) | 4 (33.3) | ||
| T stage | 1–2 | 28 | 16 (57.1) | 12 (42.9) | 0.056 |
| 3–4 | 15 | 4 (26.7) | 11 (73.3) | ||
| HBV status | Negative | 11 | 9 (81.8) | 2 (18.2) | 0.010 |
| Positive | 35 | 13 (37.1) | 22 (76.1) | ||
| AFP level | Low (<upper limit) | 18 | 13 (72.2) | 5 (27.8) | 0.004 |
| High (≥upper limit) | 25 | 7 (28.0) | 18 (72.0) | ||
| Differentiation | High | 17 | 9 (52.9) | 8 (47.1) | 0.494 |
| Low | 26 | 11 (42.3) | 15 (57.7) | ||
| CEA | Negative | 8 | 5 (62.5) | 3 (37.5) | 0.199 |
| Positive | 12 | 4 (33.3) | 8 (66.7) | ||
| GPC-3 | Negative | 7 | 3 (42.9) | 4 (57.1) | 0.606 |
| Positive | 26 | 14 (53.8) | 12 (46.2) | ||
P-value was obtained from Pearson's χ2 test or Fisher's exact test. CTAG2, cancer/testis antigen 2; HBV, hepatitis B virus; AFP, α-fetoprotein; CEA, carcinoembryonic antigen; GPC-3, glypican-3.